CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy

Bone Marrow Transplantation · Published 2026-07-16 · DOI 10.1038/s41409-026-02971-5

Free full text

Authors (23)

Luigi Carriero, Lucia Di Re, Francesco Guardalupi, Raffaella Giancola, Fabrizia Colasante, Giulia Corradi, Francesca Troiano, Noemi Michetti, Giuseppina Ricciuti, Luana Schiattone, Annalisa Natale, Nicole Santoro, Matteo Emidio Dragani, Corrado Colasante, Ida Villanova, Antonello Brattelli, Valentina De Thomasis, Ornella Iuliani, Cecilia Passeri, Stella Santarone, Paola Lanuti, Elsa Pennese, Mauro Di Ianni

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Carriero, L., Re, L., Guardalupi, F., et al. (2026). CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-026-02971-5

Related articles